Ally Bridge Group (Ny) LLC Essa Pharma Inc. Transaction History

Ally Bridge Group (Ny) LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.56 - $3.55 $1.47 Million - $2.04 Million	-574,972 Reduced 70.85%	236,583 $702,000
Q4 2022 Feb 14, 2023	BUY	$1.5 - $4.82 $1.22 Million - $3.91 Million	811,555 New	811,555 $2.05 Million
Q3 2021 Nov 15, 2021	SELL	$7.76 - $29.37 $2.82 Million - $10.7 Million	-363,185 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$11.61 - $32.08 $3.31 Million - $9.14 Million	285,000 Added 364.52%	363,185 $10.6 Million
Q4 2020 Feb 16, 2021	BUY	$5.47 - $12.1 $427,671 - $946,038	78,185 New	78,185 $933,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $72.3M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.